Literature DB >> 33766428

Epidemiology and mortality of Cushing's syndrome.

Osamah A Hakami1, Shahzada Ahmed2, Niki Karavitaki3.   

Abstract

Endogenous Cushing's syndrome (CS) is a rare endocrine disorder characterised by excess cortisol secretion due to either ACTH-dependent conditions [commonly an ACTH-producing pituitary adenoma (Cushing's disease)] or ACTH-independent causes (with most common aetiology being a benign adrenal adenoma). Overall, the annual incidence of CS ranges between 1.8 and 3.2 cases per million population. Mortality in active CS is elevated compared to the general population, and a number of studies support the view that survival is also compromised even after apparent successful treatment. The main cause of death is cardiovascular disease highlighting the negative impact of cortisol excess on cardiovascular risk factors. Early diagnosis and prompt treatment of the cortisol excess, as well as vigilant monitoring and stringent control of cardiovascular risk factors are key elements for the long-term prognosis of these patients.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cushing’s disease; Cushing’s syndrome; incidence; mild autonomous cortisol secretion; prevalence; standardised mortality ratio (SMR)

Year:  2021        PMID: 33766428     DOI: 10.1016/j.beem.2021.101521

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  7 in total

1.  Surgical outcome of transsphenoidal surgery in Cushing's disease: a case series of 1106 patients from a single center over 30 years.

Authors:  Congxin Dai; Ming Feng; Bowen Sun; Xinjie Bao; Yong Yao; Kan Deng; Zuyuan Ren; Binghao Zhao; Lin Lu; Renzhi Wang; Jun Kang
Journal:  Endocrine       Date:  2021-08-20       Impact factor: 3.633

Review 2.  Cardiovascular health and mortality in Cushing's disease.

Authors:  Amy Coulden; Ross Hamblin; John Wass; Niki Karavitaki
Journal:  Pituitary       Date:  2022-07-22       Impact factor: 3.599

3.  Vitamin D Deficiency in Cushing's Disease: Before and After Its Supplementation.

Authors:  Valentina Guarnotta; Francesca Di Gaudio; Carla Giordano
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

Review 4.  Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).

Authors:  Jih-Kai Huang; Hsiang-Chun Lee
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

5.  Recognising and diagnosing Cushing's syndrome in primary care: challenging but not impossible.

Authors:  Kate Scoffings; Damian Morris; Andrew Pullen; Sharon Temple; Anna Trigell; Mark Gurnell
Journal:  Br J Gen Pract       Date:  2022-07-28       Impact factor: 6.302

Review 6.  Pachychoroid Spectrum Diseases in Patients with Cushing's Syndrome: A Systematic Review with Meta-Analyses.

Authors:  Jeppe K Holtz; Janni M E Larsson; Michael S Hansen; Elon H C van Dijk; Yousif Subhi
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

Review 7.  The diagnosis and management of Cushing's syndrome in pregnancy.

Authors:  Ross Hamblin; Amy Coulden; Athanasios Fountas; Niki Karavitaki
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.